000

KOREAN DRUG

No trades
See on Supercharts
Market capitalization
‪70.67 B‬KRW
‪−4.92 B‬KRW
‪81.37 B‬KRW
‪5.16 M‬
Beta (1Y)
0.26

About KOREAN DRUG

Headquarters
Icheon-si
Employees (FY)
267
Founded
1980
ISIN
KR7014570006
FIGI
BBG000DWCD48
KOREAN DRUG Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It offers three types of products: over-the-counter (OTC), other drugs, and health food. Its products include remedies for respiratory diseases, topical agents for dermatoses, antibiotics and chemotherapeutics, hypnotics, antiulcer agents, antihistaminic, amino acid nutrients, antifungal agents, and home pregnancy test kit. The company was founded on January 10, 1980 and is headquartered in Icheon-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 014570 is 6570 KRW — it has decreased by 0.61% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KOREAN DRUG stocks are traded under the ticker 014570.
014570 stock is 1.69% volatile and has beta coefficient of 0.26. Check out the list of the most volatile stocks — is KOREAN DRUG there?
Yes, you can track KOREAN DRUG financials in yearly and quarterly reports right on TradingView.
014570 stock has risen by 0.77% compared to the previous week, the month change is a 0.76% fall, over the last year KOREAN DRUG has showed a 1.35% decrease.
014570 net income for the last quarter is ‪−5.32 B‬ KRW, while the quarter before that showed ‪1.84 B‬ KRW of net income which accounts for −389.22% change. Track more KOREAN DRUG financial stats to get the full picture.
Today KOREAN DRUG has the market capitalization of ‪71.30 B‬, it has decreased by 0.15% over the last week.
Yes, 014570 dividends are paid annually. The last dividend per share was 150.00 KRW. As of today, Dividend Yield (TTM)% is 2.27%. Tracking KOREAN DRUG dividends might help you take more informed decisions.
Like other stocks, 014570 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KOREAN DRUG stock right from TradingView charts — choose your broker and connect to your account.
014570 reached its all-time high on May 27, 2020 with the price of 15800 KRW, and its all-time low was 760 KRW and was reached on Jun 21, 2004.
See other stocks reaching their highest and lowest prices.
As of Apr 20, 2024, the company has 267.00 employees. See our rating of the largest employees — is KOREAN DRUG on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KOREAN DRUG technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KOREAN DRUG stock shows the sell signal. See more of KOREAN DRUG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KOREAN DRUG EBITDA is ‪19.32 B‬ KRW, and current EBITDA margin is 23.74%. See more stats in KOREAN DRUG financial statements.